NZ501990A - Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody - Google Patents

Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody

Info

Publication number
NZ501990A
NZ501990A NZ501990A NZ50199098A NZ501990A NZ 501990 A NZ501990 A NZ 501990A NZ 501990 A NZ501990 A NZ 501990A NZ 50199098 A NZ50199098 A NZ 50199098A NZ 501990 A NZ501990 A NZ 501990A
Authority
NZ
New Zealand
Prior art keywords
antigen
recognise
recombinant
antibody
compositions containing
Prior art date
Application number
NZ501990A
Other languages
English (en)
Inventor
Michael D Dan
Original Assignee
Viventia Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viventia Biotech Inc filed Critical Viventia Biotech Inc
Publication of NZ501990A publication Critical patent/NZ501990A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • C07K16/4258—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig
    • C07K16/4266—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig against anti-receptor Ig against anti-tumor receptor Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NZ501990A 1997-07-08 1998-07-08 Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody NZ501990A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5194597P 1997-07-08 1997-07-08
PCT/IB1998/001046 WO1999002545A2 (fr) 1997-07-08 1998-07-08 Fragments de liaison antigeniques designes par 4b5, qui detectent specifiquement les cellules cancereuses, nucleotides codant lesdits fragments et leur utilisation pour la prophylaxie et la detection des cancers

Publications (1)

Publication Number Publication Date
NZ501990A true NZ501990A (en) 2002-09-27

Family

ID=21974384

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ501990A NZ501990A (en) 1997-07-08 1998-07-08 Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody

Country Status (6)

Country Link
EP (1) EP1000082A2 (fr)
JP (1) JP2001509369A (fr)
AU (1) AU7927398A (fr)
CA (1) CA2295375A1 (fr)
NZ (1) NZ501990A (fr)
WO (1) WO1999002545A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309360T1 (de) 1994-03-08 2005-11-15 Human Genome Sciences Inc Vaskularer endothelialer wachstumsfaktor 2
US7153827B1 (en) 1994-03-08 2006-12-26 Human Genome Sciences, Inc. Vascular endothelial growth factor 2 and methods of use
US7186688B1 (en) 1994-03-08 2007-03-06 Human Genome Sciences, Inc. Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2
US6040157A (en) 1994-03-08 2000-03-21 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US7109308B1 (en) 1994-03-08 2006-09-19 Human Genome Sciences, Inc. Antibodies to human vascular endothelial growth factor 2
US5932540A (en) 1994-03-08 1999-08-03 Human Genome Sciences, Inc. Vascular endothelial growth factor 2
US6608182B1 (en) 1994-03-08 2003-08-19 Human Genome Sciences, Inc. Human vascular endothelial growth factor 2
US7223724B1 (en) 1999-02-08 2007-05-29 Human Genome Sciences, Inc. Use of vascular endothelial growth factor to treat photoreceptor cells
JP2003527116A (ja) * 2000-03-15 2003-09-16 インサイト・ゲノミックス・インコーポレイテッド ヒト免疫応答タンパク質
NZ518077A (en) 2000-08-04 2003-11-28 Human Genome Sciences Inc Biologically active fragments, analogues and derivatives of VEGF-2 for the treatment of peripheral artery diseases such as critical limb ischemia and coronary disease
DE10059930A1 (de) * 2000-11-23 2002-05-29 Fischer Peter Mittel humanen Ursprungs zur Vakzination gegen GD2-pos. Tumore
WO2002083704A1 (fr) 2001-04-13 2002-10-24 Human Genome Sciences, Inc. Facteur de croissance 2, endothelial, vasculaire
US7402312B2 (en) 2001-04-13 2008-07-22 Human Genome Sciences, Inc. Antibodies to vascular endothelial growth factor 2 (VEGF-2)
EP1380290A1 (fr) * 2002-07-09 2004-01-14 Universitair Medisch Centrum Utrecht La voie de la structure cross-béta et sa pertinence thérapeutique
US7473424B2 (en) * 2003-01-31 2009-01-06 The Scripps Research Institute Anti-dengue virus antibodies and compositions
TWI434855B (zh) * 2006-11-21 2014-04-21 Hoffmann La Roche 結合物及其在免疫分析中作為參考標準之用途
WO2015095002A1 (fr) * 2013-12-16 2015-06-25 Texas Tech University System Anticorps monoclonaux anti-ron en tant que système d'administration de médicaments cytotoxiques pour une thérapie anticancéreuse ciblée

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5653977A (en) * 1993-09-09 1997-08-05 Uab Research Foundation Anti-idiotypic antibody that mimics the GD2 antigen
DK0796280T3 (da) * 1994-12-28 2003-04-22 Univ Kentucky Murint monoklonalt anti-idiotypisk antistof 3H1
US5612030A (en) * 1995-01-17 1997-03-18 University Of Kentucky Research Foundation Anti-idiotype monoclonal antibody 1A7 and use for the treatment of melanoma and small cell carcinoma

Also Published As

Publication number Publication date
WO1999002545A2 (fr) 1999-01-21
EP1000082A2 (fr) 2000-05-17
JP2001509369A (ja) 2001-07-24
WO1999002545A3 (fr) 1999-04-01
CA2295375A1 (fr) 1999-01-21
AU7927398A (en) 1999-02-08

Similar Documents

Publication Publication Date Title
NZ501990A (en) Compositions containing antigen-binding fragments that recognise the antigen recognised by a recombinant 4B5 antibody
NZ337413A (en) Antibodies that bind to Prostate Stem Cell Antigen (PSCA) to treat prostate cancer.
IL139700A (en) Immunotherapeutic composition for the treatment of prostate cancer
AU2821195A (en) Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin
AU3117201A (en) Methods and compositions for generating human monoclonal antibodies
ES8405071A1 (es) Un procedimiento de preparacion de conjugados inmunoenzimaticos.
HK1076128A1 (en) Humanized collagen antibodies and related methods
WO1997046589A3 (fr) Anticorps humanises se liant au meme antigene que celui lie par l'anticorps nr-lu-13 et leur utilisation dans des procedes de preciblage
ZA945364B (en) Antibodies specific for human prostate glandular kallikrein
AU3327701A (en) Humanized anti-ccr2 antibodies and methods of use therefor
UA89017C2 (uk) ЛЮДСЬКЕ АНТИТІЛО, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ЛЮДСЬКИМ TNFSF13b
GEP20104997B (en) Composition comprising anther2 antibodies
AR085874A2 (es) Un anticuerpo monoclonal o un fragmento del mismo que se une a un antigeno
MY145191A (en) Human antibodies that bind human il-12 and methods for producing
NO942850D0 (fr)
BR9809778A (pt) Polinucleotìdeo isolado, vetor de expressão, peptìdeo ou polipetìdeo isolado, anticorpo, processo para produzir o mesmo, fragmentos de anticorpos, anticorpos de cadeia única ou anticorpos humanizados, e, anticorpo anti-idiotìpico.
AU676859B2 (en) Synthetic peptides, antibodies against them and their use
CA2068222A1 (fr) Anticorps monoclonaux
EP2088158A3 (fr) Anticorp monoclonal contre le récepteur CCR5 de chimokine.
EP1411962A4 (fr) Traitement par anticorps monoclonal du cancer du pancreas
IL187595A (en) Pharmaceutical preparation containing monoclonal antibody - tumors and production
SI1396501T1 (sl) Protitelesa za identifikacijo in/ali izolacijo najmanj ene celiäśne populacije, ki je izbrana iz skupine, ki obsega hematopoetske matiäśne celice, nevronske matiäśne celice, nevronske prekurzorske celice, mezenhimske matiäśne celice in mezenhimske pr
AU2911289A (en) Carcinoma-associated antigens, and antibodies which recognize these antigens
MY103231A (en) Immunoglobulin conjugates
HK1036654A1 (en) Method for determining a gushing factor for a beverage.

Legal Events

Date Code Title Description
ASS Change of ownership

Owner name: VIVENTIA BIOTECH INC, CA

Free format text: OLD OWNER(S): NOVOPHARM BIOTECH INCORPORATED

PSEA Patent sealed
RENW Renewal (renewal fees accepted)